Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
City of Hope Medical Center
Children's Hospitals and Clinics of Minnesota
West China Hospital
University of South Florida
Jonsson Comprehensive Cancer Center
Acrotech Biopharma Inc.
National Institutes of Health Clinical Center (CC)
University Hospital, Angers
Children's Oncology Group
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
University of Louisville
Fred Hutchinson Cancer Center
Columbia University
SillaJen, Inc.
Children's Oncology Group
University of South Florida
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Muenster
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)